BAHAX
Price
$18.13
Change
+$0.07 (+0.39%)
Updated
Sep 11 closing price
Net Assets
671.76M
VEUSX
Price
$112.47
Change
+$0.73 (+0.65%)
Updated
Sep 11 closing price
Net Assets
39.06B
Interact to see
Advertisement

BAHAX vs VEUSX

BAHAX vs VEUSX Comparison Chart in %
View a ticker or compare two or three
VS
BAHAX vs. VEUSX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAHAX is a StrongBuy and VEUSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEUSX has more cash in the bank: 39.1B vs. BAHAX (672M). VEUSX pays higher dividends than BAHAX: VEUSX (2.79) vs BAHAX (1.05). BAHAX was incepted earlier than VEUSX: BAHAX (13 years) vs VEUSX (25 years). BAHAX (1.45) is less costly to investors than VEUSX (0.08). BAHAX is a more actively managed with annual turnover of: 47.00 vs. VEUSX (5.00). BAHAX has a lower initial minimum investment than VEUSX: BAHAX (100) vs VEUSX (3000). VEUSX annual gain was more profitable for investors over the last year : 12.76 vs. BAHAX (-1.28). BAHAX return over 5 years is better than : 41.79 vs. VEUSX (31.12).
BAHAXVEUSXBAHAX / VEUSX
Total Expense Ratio1.450.081,813%
Annual Report Gross Expense Ratio1.450.081,813%
Fund Existence13 years25 years-
Gain YTD2.7897.23639%
Front LoadN/AN/A-
Min. Initial Investment10030003%
Min. Initial Investment IRAN/AN/A-
Net Assets672M39.1B2%
Annual Yield % from dividends1.052.7938%
Returns for 1 year-1.2812.76-10%
Returns for 3 years64.0450.61127%
Returns for 5 years41.7931.12134%
Returns for 10 years89.9991.5698%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAZBX41.160.27
+0.66%
Oakmark Equity and Income R6
PGIOX40.12N/A
N/A
Putnam Focused Equity R
SVSPX310.55N/A
N/A
State Street S&P 500 Index N
ISCTX20.54N/A
N/A
Voya SmallCap Opportunities Port S2
EEMFX12.78N/A
N/A
MFS Emerging Markets Equity Research R3